What is Qinlock?
Qinlock is a prescription oral medication used to treat a specific type of cancer. It contains the active ingredient ripretinib. This medicine is a targeted therapy. It is designed for adults with advanced gastrointestinal stromal tumors (GIST). Qinlock is used after at least three other kinase inhibitor treatments have been tried. It offers a new option when the cancer stops responding to previous therapies. This drug helps manage the disease progression.
How does Qinlock work?
Qinlock works by blocking specific enzymes known as kinases. In GIST, kinases like KIT and PDGFRA can become overactive. This overactivity causes cancer cells to grow and multiply uncontrollably. Qinlock acts as a broad-spectrum kinase inhibitor. It targets a wide range of these mutations. By blocking these signals, it effectively slows or stops the growth of tumors. This targeted approach helps control the cancer’s progression. It focuses on the underlying drivers of the disease.
Who is Qinlock for?
Qinlock is for adults diagnosed with advanced gastrointestinal stromal tumors (GIST). It is specifically intended for patients who have already received several other treatments. These patients have seen their disease progress despite therapy with at least three different kinase inhibitors, such as imatinib. Qinlock is considered a fourth-line treatment. It provides a crucial option for individuals whose tumors have developed resistance to other targeted drugs. Your oncologist can determine if Qinlock is the right choice for your condition.
Dosage and administration
Qinlock is typically prescribed as a 150 mg oral tablet. The standard dosage is one tablet taken once daily. You can take Qinlock with or without food. It is important to swallow the tablet whole. Do not crush, split, or chew it. Try to take your dose at the same time each day. This helps maintain a consistent level of the medication in your body. Always follow your doctor’s instructions for dosage. Do not change your dose without consulting your healthcare provider.
Side effects
Qinlock may cause side effects, which can range from mild to serious. It is important to discuss these with your doctor. Common side effects often include hair loss, fatigue, nausea, and muscle pain. Other possible issues include abdominal pain, diarrhea, and vomiting. Some patients may experience hand-foot syndrome. This involves redness and pain on the hands and feet. More serious side effects can occur, like high blood pressure, heart problems, and new skin cancers. Contact your doctor if you experience any severe or concerning symptoms while taking Qinlock.
Why buy from IsraelPharm?
IsraelPharm provides a reliable and cost-effective way to get your medications. We are committed to patient health and safety. Our pharmacy sources genuine, brand-name drugs directly from authorized distributors in Israel. This allows us to offer significant savings to our customers. Our team is dedicated to providing excellent service and support. We ensure your prescription is filled accurately and shipped securely. Choose IsraelPharm for affordable access to the treatments you need. We make managing your health simpler and more affordable.
Potential Side Effects of Qinlock
Like all medications, Qinlock may cause side effects. It is important to be aware of them and speak to your doctor if you have concerns.
Common Side Effects:
- Hair loss (alopecia)
- Fatigue or weakness
- Nausea and vomiting
- Abdominal pain
- Constipation or diarrhea
- Muscle aches (myalgia)
- Decreased appetite
- Hand-foot syndrome (redness, swelling, and pain on palms or soles)
Serious Side Effects:
Contact your doctor immediately if you experience any of the following:
- Signs of new skin cancers
- Severe high blood pressure (hypertension)
- Symptoms of heart problems (chest pain, shortness of breath, swelling in legs)
- Signs of liver problems (yellowing skin, dark urine)
- Severe stomach pain
What Qinlock Treats
Qinlock (ripretinib) is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
- Advanced Gastrointestinal Stromal Tumor (GIST): A type of tumor that occurs in the gastrointestinal tract, most commonly in the stomach or small intestine.
- Fourth-Line Treatment: Used when the disease has progressed after multiple previous lines of targeted therapy.